The survival rate is higher in the high KLF17 expression group than in the low KLF17 expression group of patients with HCC, and the downregulated KLF17 expression is associated with the poor prognosis of HCC [18]. The gene discussed is KLF17; the disease is hepatocellular carcinoma.